Predictors and Clinical Impact of Super-Response in Vitiligo Patients Treated with Topical Ruxolitinib: A Real-World Cohort Study From a Turin Vitiligo Registry.

Opzelura (ruxolitinib cream) - Incyte

Predictors and Clinical Impact of Super-Response in Vitiligo Patients Treated with Topical Ruxolitinib: A Real-World Cohort Study From a Turin Vitiligo Registry. (PubMed, J Am Acad Dermatol) - Aug 29, 2026 - No abstract available
Journal • Real-world evidence • Dermatology • Immunology • Vitiligo

http://www.ncbi.nlm.nih.gov/pubmed/42665024

Chiara Anna Fiasconaro; Francesco Leo; Luca Cangialosi; Luca Mastorino; Maria Giulia Bailon; Pietro Quaglino; Rachele Milanaccio; Simone Ribero

Aug 29, 2026